CAPS Rating

TMFmd19 (93.98)

Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
27/02/2012 SJM.US 4 out of 5 Outperform 5Y $72.20 $103.22 (+0.73%) +42.97% +21.53% +21.44 1 Reply
20/09/2011 BMC.US 4 out of 5 Outperform 5Y $42.12 $45.55 (+0.66%) +8.14% +36.21% -28.07
14/09/2011 GTI.US 4 out of 5 Outperform 5Y $15.85 $8.45 (+1.81%) -46.69% +39.69% -86.38
14/09/2011 BR.US 3 out of 5 Outperform 5Y $19.48 $27.42 (+0.81%) +40.78% +39.69% +1.09
08/09/2011 MA.US 4 out of 5 Outperform 5Y $335.67 $571.46 (+0.30%) +70.24% +38.18% +32.06
31/08/2011 AXP.US 4 out of 5 Outperform 5Y $47.81 $75.27 (+0.78%) +57.44% +34.99% +22.45
11/08/2011 GSK.US 4 out of 5 Outperform 5Y $35.51 $52.97 (+0.46%) +49.17% +45.95% +3.21
11/08/2011 ORCL.US 4 out of 5 Outperform 5Y $26.08 $34.05 (-0.53%) +30.55% +45.95% -15.41
10/08/2011 BRK-B.US 5 out of 5 Outperform 5Y $69.54 $110.83 (-0.41%) +59.38% +45.30% +14.08 1 Reply
27/10/2011 PSMT.US 5 out of 5 Outperform 5Y $75.56 $87.00 (+0.08%) +15.14% +29.02% -13.87 1 Reply
28/11/2011 ATHN.US 2 out of 5 Outperform 5Y $55.75 $85.82 (+0.68%) +53.94% +38.82% +15.12 1 Reply
27/02/2012 K.US 4 out of 5 Outperform 3Y $50.61 $64.45 (-0.37%) +27.35% +21.53% +5.82 1 Reply
23/02/2012 PG.US 4 out of 5 Outperform 5Y $61.78 $81.88 (+4.04%) +32.54% +21.59% +10.95 2 Replies
17/02/2012 LNKD.US 1 out of 5 Outperform 5Y $91.64 $173.80 (-1.43%) +89.66% +21.09% +68.57 1 Reply
08/02/2012 CME.US 4 out of 5 Outperform 5Y $52.42 $64.54 (+0.64%) +23.11% +23.07% +0.04
18/01/2012 SBUX.US 4 out of 5 Outperform 5Y $46.83 $63.36 (-0.25%) +35.29% +27.84% +7.45
06/01/2012 EXPD.US 4 out of 5 Outperform 5Y $40.40 $39.33 (-2.02%) -2.65% +28.95% -31.60 1 Reply
30/12/2011 AMZN.US 2 out of 5 Outperform 5Y $173.49 $261.74 (-0.02%) +50.87% +31.15% +19.73 1 Reply
13/12/2011 PACR.US 4 out of 5 Outperform 5Y $4.67 $6.24 (-0.16%) +33.62% +32.49% +1.13 3 Replies
09/08/2011 PRAA.US 5 out of 5 Outperform 5Y $68.76 $147.12 (+0.43%) +113.96% +46.64% +67.32

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.